Characterization of the murine plasminogen/urokinase-type plasminogen-activator system

European Journal of Biochemistry

Volumn 241, Issue 3, 1996, Pages 840-848

  Lijnen, H Roger ^a   Van Hoef, Berthe ^a   Collen, Désiré ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Endothelioma cell; Murine fibrinolysis; Plasminogen; Urokinase type plasminogen activator

Indexed keywords

PLASMINOGEN; PLASMINOGEN ACTIVATOR; RECOMBINANT PROTEIN; UROKINASE;

ARTICLE; CELL ADHESION; ENZYME ACTIVITY; FIBRINOLYSIS; GENE EXPRESSION; HUMAN; IN VITRO STUDY; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PURIFICATION; SPECIES DIFFERENCE;

MURINAE;

EID: 0029862367     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.1996.00840.x     Document Type: Article

References (32)

1. Collen, D. & Lijnen, H. R. (1991) Basic and clinical aspects of fibrinolysis and thrombolysis, Blood 78, 3114-3124.
2. Blasi, F. (1993) Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness, Bioessays 15, 105-111.
3. Heckel, J. L., Sandgren, E. P., Degen, J. L., Palmiter, R. D. & Brinster, R. L (1990) Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator, Cell 62, 447-456.
4. Carmeliet, P., Schoonjans, L., Kieckens, L., Ream, B., Degen, J., Bronson, R., De Vos, R., van den Oord, J. J., Collen, D. & Mulligan, R. C. (1994) Physiological consequences of loss of plasminogen activator gene function in mice, Nature 368, 419-424.
5. Lijnen, H. R., Van Hoef, B., Beelen, V. & Collen, D. (1994) Characterization of the murine plasma fibrinolytic system, Eur. J. Biochem. 224, 863-871.
6. Holvoet, P., Laroche, Y., Lijnen, H. R., Van Hoef, B., Brouwers, E., De Cock, F., Lauwereys, M., Gansemans, Y. & Collen, D. (1992) Biochemical characterization of single-chain chimeric plasminogen activators consisting of a single-chain Fv fragment of a fibrin-specific antibody and single-chain urokinase, Eur. J. Biochem. 210, 945-952.
7. Astrup, T. & Müllertz, S. (1952) Fibrin plate method for estimating fibrinolytic activity, Arch. Biochem. Biophys. 40, 346-351.
8. Alessi, M. C., Declerck, P. J., De Mol, M., Nelles, L. & Collen, D. (1988) Purification and characterization of natural and recombinant human plasminogen activator inhihitor-1 (PAI-1), Eur. J. Biochem. 175, 531-540.
9. Carmeliet, P., Kieckens, L., Schoonjans, L., Ream, B., Van Nuffelen, A., Prendergast, G., Cole, M., Bronson, R., Collen, D. & Mulligan R. C. (1993) Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization, J. Clin. Invest. 92, 2746-2755.
10. Declerck, P., Carmeliet, P., Verstreken, M., De Cock, F. & Collen, D. (1995) Generation of monoclonal antibodies against autologous proteins in gene-inactivated mice, J. Biol. Chem. 270, 8397-8400.
11. Solberg, H., Rømer, J., Brünner, N., Holm, A., Sidenius, N., Danø, K. & Hoyer-Hansen, G. (1994) A cleaved form of the receptor for urokinase-type plasminogen activator in invasive transplanted human and murine tumors, Int. J. Cancer 58, 877-881.
12. Towbin, H., Staehelin, T. & Gordon, J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications, Proc. Natl Acad. Sci. USA 76, 4350-4354.
13. Declerck, P. J., Verstreken, M. & Collen, D. (1995) Immunoassay of murine t-PA, u-PA and PAI-1 using monoclonal antibodies raised in gene-inactivated mice, Thromb. Haemostas. 74, 1305-1309.
14. Wagner, E. F. & Risau, W. (1994) Oncogenes in the study of endothelial cell growth and differentiation, Semin. Cancer Biol. 5, 137-145.
15. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72, 248-254.
16. Scatchard, G. (1949) The attractions of proteins for small molecules and ions, Ann. NY Acad. Sci. 51, 660-672.
17. Stoppelli, M. P., Tacchetti, C., Cubellis, M. V., Corti, A., Hearing, V. J., Cassani, G., Appella, E. & Blasi, F. (1986) Autocrine saturation of pro-urokinase receptors on human A431 cells, Cell 45, 675-684.
18. Belin, D., Vassalli, J. D., Combepine, C., Godeau, F., Nagamine, Y., Reich, E., Kocher, H. P. & Duvoisin, R. M. (1985) Cloning, nucleotide sequencing and expression of cDNA's encoding mouse urokinase-type plasminogen activator, Eur. J. Biochem. 148, 225-232.
19. Degen, S. J. F., Bell, S. M., Schaefer, M. A. & Elliott, R. W. (1990) Characterization of the cDNA coding for mouse plasminogen and localization of the gene to mouse chromosome 17, Genomics 8, 49-61.
20. Dewerchin, M., Van Nuffelen, A., Wallays, G., Bouché, A., Moons, L., Carmeliet, P., Mulligan, R. C. & Collen, D. (1996) Generation and characterization of urokinase receptor-deficient mice, J. Clin. Invest. 97, 870-878.
21. Carmeliet, P. & Collen, D. (1995) Gene targeting and gene transfer studies of the biological role of the plasminogen/plasmin system, Thromb. Haemostas. 74, 429-436.
22. Carmeliet, P., Stassen, J. M., Schoonjans, L., Ream, B., van den Oord, J. J., De Mol, M., Mulligan, R. C. & Collen, D. (1993) Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis, J. Clin. Invest. 92, 2756-2760.
23. Bugge, T. H., Suh, T. T., Flick, M. J., Daugherty, C. C., Rømer, J. R., Solberg, H., Ellis, V., Danø, K. & Degen, J. L. (1995) The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility, J. Biol. Chem. 270, 16 886-16 894.
24. Bugge, T. H., Flick, M. J., Daugherty, C. C. & Degen, J. L. (1995) Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction, Genes & Dev. 9, 794-807.
25. Ploplis, V. A., Carmeliet, P., Vazirzadeh, S., Van Vlaenderen, I., Moons, L., Plow, E. F. & Collen, D. (1995) Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice, Circulation 92, 2585-2593.
26. Sottrup-Jensen, L., Claeys, H., Zajdel, M., Petersen, T. E. & Magnusson, S. (1978) The primary structure of human plasminogen: isolation of two lysine-binding fragments and one 'mini-' plasminogen (MW, 38,000) by elastase-catalyzed-specific limited proteolysis, in Progress in chemical fibrinolysis and thrombolysis 3 (Davidson, J. F., Rowan, R. M., Samama, M. M. & Desnoyers, P. C., eds) pp. 191-209, Raven Press, New York.
27. Thorsen, S., Kok, P. & Astrup, T. (1974) Reversible and irreversible alterations of human plasminogen indicated by changes in susceptibility to plasminogen activators and in response to epsilon-aminocaproic acid, Thromb. Diath. Haemorrh. 32, 325-340.
28. 2-antiplasmin to fibrin is a key factor in regulating blood clot lysis: species differences, Blood Coag. Fibrinol. 4, 869-875.
29. van Giezen, J. J. J., Bouma, B. N. & Jansen, J. W. C. M. (1994) Mice release less tissue-type plasminogen activator (t-PA) and have more active clot stabilization by FXIII compared to rats which might explain their low rate of blood clot lysis, Fibrinolysis 8, 1-8.
30. Ellis, V., Behrendt, N. & Danø, K. (1991) Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor, J. Biol. Chem. 266, 12752-12758.
31. Ellis, V., Scully, M. F. & Kakkar, V. V. (1989) Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes, J. Biol. Chem. 264, 2185-2188.
32. Ellis, V., Wun, T. C., Behrendt, N., Ronne, E. & Danø, K. (1990) Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors, J. Biol. Chem. 265, 9904-9908.